Ownership history in XTX Topco Ltd · 8 quarters on record
This page tracks every 13F SEC filing in which XTX Topco Ltd reported a position in ALX ONCOLOGY HLDGS INC (ALXO). Data includes quarterly share count, position size as % of portfolio, estimated market value, and end-of-quarter stock price — sourced directly from SEC EDGAR 13F filings.
| Quarter | Action | Shares | Change | Chg % | % of Fund | Mkt Value | Price (EOQ) |
|---|---|---|---|---|---|---|---|
| 2025 Q3 | REDUCED | 26,621 | -48,149 | -64.4% | 0.00% | $49K | $1.83 |
| 2025 Q2 | REDUCED | 74,770 | -17,489 | -19.0% | 0.00% | $31K | $0.41 |
| 2025 Q1 | REDUCED | 92,259 | -171,597 | -65.0% | 0.00% | $57K | $0.62 |
| 2024 Q4 | REDUCED | 263,856 | -53,466 | -16.8% | 0.04% | $441K | $1.67 |
| 2024 Q3 | ADDED | 317,322 | +306,411 | +2808.3% | 0.04% | $578K | $1.82 |
| 2024 Q1 | ADDED | 10,911 | +171 | +1.6% | 0.02% | $122K | $11.15 |
| 2023 Q3 | REDUCED | 10,740 | -15,077 | -58.4% | 0.01% | $52K | $4.80 |
| 2023 Q1 | INITIATED | 25,817 | — | — | 0.02% | $117K | $4.52 |
As of 2025 Q4 — sorted by position size